Cargando…

GeneXpert for TB diagnosis: planned and purposeful implementation

Xpert MTB/RIF is a major advance for TB diagnostics, especially for multidrug-resistant (MDR) TB and HIV-associated TB. But implementation concerns including cost, technical support requirements, and challenging demands of providing second-line TB drugs for diagnosed MDR-TB cases call for gradual, c...

Descripción completa

Detalles Bibliográficos
Autores principales:	Piatek, Amy S, Van Cleeff, Maarten, Alexander, Heather, Coggin, William L, Rehr, Manuela, Van Kampen, Sanne, Shinnick, Thomas M, Mukadi, YaDiul
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Global Health: Science and Practice 2013
Materias:	Commentaries
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4168558/ https://www.ncbi.nlm.nih.gov/pubmed/25276513 http://dx.doi.org/10.9745/GHSP-D-12-00004

Ejemplares similares

Contributions of GeneXpert(®) to TB diagnosis in Myanmar
por: Burger, Z., et al.
Publicado: (2022)

Prospective evaluation of GeneXpert for the diagnosis of HIV- negative pediatric TB cases
por: Giang, Do Chau, et al.
Publicado: (2015)

Equivalence of the GeneXpert System and GeneXpert Omni System for tuberculosis and rifampicin resistance detection
por: Georghiou, Sophia B., et al.
Publicado: (2021)

An observational report of universal GeneXpert testing of inpatients with diagnosed or presumptive TB in the Philippines
por: Thi, Aye Myat, et al.
Publicado: (2020)

Implementation of GeneXpert for TB Testing in Low- and Middle-Income Countries: A Systematic Review
por: Brown, Scott, et al.
Publicado: (2021)

Evaluation of the GeneXpert for Human Monkeypox Diagnosis
por: Li, Daniel, et al.
Publicado: (2017)

GeneXpert for the diagnosis of COVID-19 in LMICs
por: Rakotosamimanana, Niaina, et al.
Publicado: (2020)

Meeting the 2030 END TB goals in the wake of COVID-19: A modelling study of countries in the USAID TB portfolio
por: Arinaminpathy, Nimalan, et al.
Publicado: (2023)

Multidisease testing for HIV and TB using the GeneXpert platform: A feasibility study in rural Zimbabwe
por: Ndlovu, Zibusiso, et al.
Publicado: (2018)

Diagnostic performance of GeneXpert MTB/RIF in detecting MTB in smear-negative presumptive TB patients
por: Rimal, Raksha, et al.
Publicado: (2022)

Rolling out Xpert MTB/RIF(®) for tuberculosis detection in HIV-positive populations: An opportunity for systems strengthening
por: Pathmanathan, Ishani, et al.
Publicado: (2017)

Evaluation of GeneXpert MTB/RIF for Diagnosis of Tuberculous Meningitis
por: Nhu, Nguyen Thi Quynh, et al.
Publicado: (2014)

P388 High rate of chronic pulmonary aspergillosis in active TB patients in Indonesia with GeneXpert positive
por: Setianingrum, Findra, et al.
Publicado: (2022)

The Impact and Cost of Scaling up GeneXpert MTB/RIF in South Africa
por: Meyer-Rath, Gesine, et al.
Publicado: (2012)

GeneXpert—A Game-Changer for Tuberculosis Control?
por: Evans, Carlton A.
Publicado: (2011)

GeneXpert in stool: Diagnostic yield in Intestinal Tuberculosis
por: Talib, Abu, et al.
Publicado: (2019)

Impact of GeneXpert MTB/RIF® on treatment initiation and outcomes of RIF-resistant and RIF-susceptible TB patients in Vladimir TB dispensary, Russia
por: Ershova, Julia V., et al.
Publicado: (2020)

WHO laboratory validation of Xpert(®) CT/NG and Xpert(®) TV on the GeneXpert system verifies high performances
por: Jacobsson, Susanne, et al.
Publicado: (2018)

Comparative Performance of Line Probe Assay and GeneXpert in the Detection of Rifampicin Monoresistance in a TB-Endemic African Country
por: Mchaki, Betty R., et al.
Publicado: (2022)

Impact of the use of GeneXpert on TB diagnosis and anti-TB treatment outcome at health facilities in Addis Ababa, Ethiopia in the post-millennium development years
por: Getahun, Desalegn Addise, et al.
Publicado: (2023)

Public investments in the development of GeneXpert molecular diagnostic technology
por: Gotham, Dzintars, et al.
Publicado: (2021)

Comparison of LAMP, GeneXpert, Mycobacterial Culture, Smear Microscopy, TSPOT.TB, TBAg/PHA Ratio for Diagnosis of Pulmonary Tuberculosis
por: Deng, Yan, et al.
Publicado: (2021)

Evaluation of Automated Molecular Testing Rollout for Tuberculosis Diagnosis Using Routinely Collected Surveillance Data — Uganda, 2012–2015
por: Scott, Colleen, et al.
Publicado: (2017)

Clinical utility of the GeneXpert assay for the diagnosis of Clostridium difficile infections
por: Florea, Dragoş, et al.
Publicado: (2014)

Evaluation of the GeneXpert MTB/RIF in patients with presumptive tuberculous meningitis
por: Metcalf, Tatiana, et al.
Publicado: (2018)

Diagnostic Accuracy of Sputum Microscopy in Comparison With GeneXpert in Pulmonary Tuberculosis
por: Umair, Masab, et al.
Publicado: (2020)

Effectiveness of GeneXpert(®) in the diagnosis of tuberculosis in people living with HIV/AIDS
por: de Faria, Mariana Gaspar Botelho Funari, et al.
Publicado: (2021)

Discordance of the Repeat GeneXpert MTB/RIF Test for Rifampicin Resistance Detection Among Patients Initiating MDR-TB Treatment in Uganda
por: Ssengooba, Willy, et al.
Publicado: (2021)

Optimal Triage Test Characteristics to Improve the Cost-Effectiveness of the Xpert MTB/RIF Assay for TB Diagnosis: A Decision Analysis
por: van’t Hoog, Anna H., et al.
Publicado: (2013)

Clinical evaluation of the GeneXpert® Xpert® Xpress SARS-CoV-2/Flu/RSV combination test
por: Johnson, Grant, et al.
Publicado: (2021)

The Application of GeneXpert MTB/RIF for Smear-Negative TB Diagnosis as a Fee-Paying Service at a South Asian General Hospital
por: Shrestha, Poojan, et al.
Publicado: (2015)

Test and Treat TB: a pilot trial of GeneXpert MTB/RIF screening on a mobile HIV testing unit in South Africa
por: Bassett, Ingrid V., et al.
Publicado: (2019)

An Optimal Diagnostic Strategy for Tuberculosis in Hospitalized HIV-Infected Patients Using GeneXpert MTB/RIF and Alere Determine TB LAM Ag
por: Esmail, Aliasgar, et al.
Publicado: (2020)

Analytical Performance Characteristics of the Cepheid GeneXpert Ebola Assay for the Detection of Ebola Virus
por: Pinsky, Benjamin A., et al.
Publicado: (2015)

Role of GeneXpert MTB/Rif Assay in Diagnosing Tuberculosis in Pregnancy and Puerperium
por: Habib, Zaiyad G., et al.
Publicado: (2015)

Evaluation of GeneXpert MTB/RIF assay for direct diagnosis of pulmonary tuberculosis
por: Moussa, Husseiny Sh., et al.
Publicado: (2016)

Evaluation of GeneXpert MTB/RIF system performances in the diagnosis of extrapulmonary tuberculosis
por: Mechal, Youness, et al.
Publicado: (2019)

GeneXpert on patients with human immunodeficiency virus and smear-negative pulmonary tuberculosis
por: Cuong, Nguyen Kim, et al.
Publicado: (2021)

GeneXpert Technology for the diagnosis of HIV-associated tuberculosis: Is scale-up worth it?
por: Saeed, Muhammad, et al.
Publicado: (2020)

Diagnosing an atypical case of tuberculosis presenting as dacryocystitis: Sac biopsy and GeneXpert
por: Lokdarshi, Gautam, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_e8j7lt2ha2uatqr68lui686581